Navigation Links
Aethlon Medical Note: Fiscal Year Revenue Guidance
Date:5/3/2012

er therapies, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The company undertakes no obligation to publically update or revise any forward looking statements, whether as a result of new information, future events, or otherwise.

Contacts:

James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com

Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com

Marc Robins
877.276.2467
mr@aethlonmedical.com


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
4. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
5. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
6. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
7. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
8. Aethlon Medical Releases Shareholder Letter
9. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
10. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
11. Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Calif. , Feb. 27, 2015  Finesse expands office ... Finesse Solutions announced the expansion of its operations ... is planned for mid-March and access for customers is ... the A-563, and located adjacent to the current office, ... the Finesse automation engineering team and allow Finesse to bring ...
(Date:2/26/2015)... RnRMarketResearch.com adds Corneal Ulcers ... to its store. This report p provides an ... The report "Corneal Ulcers - Pipeline Review, H2 2014" ... Corneal Ulcers. Corneal Ulcers are primarily result of ... infections & fungal infections. The symptoms of the ...
(Date:2/26/2015)... Feb. 26, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today ... 5,250,000 shares of its common stock at a price ... proceeds to Tandem from this offering are expected to ... and other estimated offering expenses payable by Tandem. All ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... OXFORD, England, September 26, 2011 EJC App Now ... provider of scientific, technical and medical information products and services, today ... Journal of Cancer ( EJC ). Starting with the September ... will be available through the EJC App on the App Store. ...
... InterMune, Inc. (NASDAQ: ITMN ) today reported ... Society (ERS) Annual Congress supporting the longer-term safety and ... idiopathic pulmonary fibrosis (IPF), a devastating lung disease.  Approximately ... year, with an estimated median survival of only two ...
Cached Medicine Technology:Elsevier Launches European Journal of Cancer iPad Edition 2Elsevier Launches European Journal of Cancer iPad Edition 3New Data Demonstrate Longer-Term Safety Profile of Esbriet® 2New Data Demonstrate Longer-Term Safety Profile of Esbriet® 3New Data Demonstrate Longer-Term Safety Profile of Esbriet® 4New Data Demonstrate Longer-Term Safety Profile of Esbriet® 5New Data Demonstrate Longer-Term Safety Profile of Esbriet® 6
(Date:2/26/2015)... (PRWEB) February 27, 2015 New ... is pleased to announce it is accepting new ... in Chesapeake, Va. , The new location ... physical therapy and rehabilitation programs, including the following ... and post orthopedic care, -Vestibular rehabilitation, -Neurological rehabilitation, ...
(Date:2/26/2015)... 2015 2015 Deep Market Research ... professional and in-depth study on the current state ... with a focus on the Chinese situation. , ... are Wuhan Youji, Tongtai, Tenlong, Zhiyuan, MILAN, Dongda, ... and W.ULRICH. , The report provides a basic ...
(Date:2/26/2015)... Portland, OR (PRWEB) February 26, 2015 ... and former professional runner Dr. Anne Shadle discusses her ... three Olympic gold medal-winning athletes in Track and Field. ... physical ability and technical training that impacted athletes’ success ... emotional traits she uncovered seem not only critical to ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 “In the ... have monitored the evolution of one of the newest ... ARTAS system offers a machinery that facilitates ... from the patient’s scalp,” said Dr. Parsa Mohebi. , ... automated, the speed at which the device extracted these ...
(Date:2/26/2015)... Imagine a day without access to clean, ... and there was no one to help. For more than ... In 2015, more than 2.5 billion people will also lack ... A new initiative led by Nevada’s Desert Research Institute ... specifically on women – who often bear the brunt of ...
Breaking Medicine News(10 mins):Health News:Tidewater Physical Therapy Accepting New Patients at Relocated Battlefield Clinic 2Health News:Global Sodium Benzoate Industry Analysis Report 2015-2020 Now at DeepResearchReports.com 2Health News:Global Sodium Benzoate Industry Analysis Report 2015-2020 Now at DeepResearchReports.com 3Health News:Anne Shadle and Controlling the Olympic Moment on SCI TV 2Health News:Anne Shadle and Controlling the Olympic Moment on SCI TV 3Health News:Newest Technology now Available at Parsa Mohebi Hair Restoration 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3
... neither improved nor deteriorated. There are 89 new cases, 2 deaths ... the number of dengue cases at the All India Institute of ... viral fever cases is also decreasing; however, the doctors cautioned that ... cases have come down but the outbreak isn't over," said Medical ...
... hopes of a team of eminent plastic surgeons led by ... waiting for the// final approval from The Royal Free hospital’s ... transplant which would involve the complete replacement of a disfigured ... ,Although the hospital had granted permission to ...
... in clinical use for decades, a small, sweet-tasting compound ... cure for epilepsy.// ,2-deoxy-glucose, or 2DG, has ... cancer imaging studies in humans. But now, researchers at ... blocks the onset of epileptic seizures in laboratory rats. ...
... must get its act together to check the perilous trend of ... suggested a cap on the// embryo, allowing only one embryo at ... the Human Fertilization and Embryology Authority (HFEA) has suggested that the ... two to one for patients who are not on the wrong ...
... Taxotere(docetaxel) from Sanofi-Aventis has been approved for its treatment ... showed that patients given chemotherapy with// Taxotere survived an ... to 8.3 months with standard drugs. ,The ... cisplatin and fluorouracil chemotherapy in locally advanced squamous cell ...
... gene therapy for Parkinson's disease has given the green signal ... symptoms for patients,// according to the reports of two groups ... and last week the researchers reported that each of the ... received some benefit and none had significant side effects. ...
Cached Medicine News:Health News:Commonplace Sugar Compound Silences Seizures 2Health News:Commonplace Sugar Compound Silences Seizures 3Health News:Gene therapy Beneficial in Parkinson's Disease 2Health News:Gene therapy Beneficial in Parkinson's Disease 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: